Conducting research in individual patients: Lessons learnt from two series of N-of-1 trials

BMC Family Practice

Volumn 7, Issue , 2006, Pages

  Wegman, Anke C M ^a   Van Der Windt, Daniëlle A W M ^a,b   Stalman, Wim A B ^a   De Vries, Theo P G M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; TEMAZEPAM; ANALGESIC AGENT; HYPNOTIC SEDATIVE AGENT;

CLINICAL TRIAL; DRUG DOSE REGIMEN; FOLLOW UP; GENERAL PRACTICE; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; PAIN; RESEARCH PRIORITY; RESEARCH SUBJECT; REVIEW; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; OSTEOARTHRITIS; PATIENT PARTICIPATION; PATIENT SELECTION; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDERS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FAMILY PRACTICE; HUMANS; HYPNOTICS AND SEDATIVES; OSTEOARTHRITIS; PATIENT PARTICIPATION; PATIENT SELECTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP DISORDERS; TEMAZEPAM; TREATMENT OUTCOME;

EID: 33749676402     PISSN: 14712296     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-7-54     Document Type: Review

References (38)

1. Altman DG: Practical statistics for medical research London: Chapman & Hall; 1991:1-9.
2. Nikles CJ, Clavarino AM, Del Mar CB: sing n-of-1 trials as a clinical tool to improve prescribing. Br J Gen Pract 2005, 55:175-80.
3. Madhok V, Fahey T: N-of-1 trials: an opportunity to tailor treatment in individual patients. Br J Gen Pract 2005, 55:172.
4. Guyatt G, Sackett D, Adachi J, Roberts R, Chong J, Rosenbloom D, Keller J: A clinician's guide for conducting randomized trials in individual patients. CMAJ 1988, 139:497-503.
5. Wegman ACM, Van der Windt DAWM, De Haan M, Devillé WLJM, Chin A, Fo CT, De Vries ThPGM: Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Ann Rheum Dis 2003, 62:1156-1161.
6. Wegman ACM, Van der Windt DAWM, Bongers M, Twisk JWR, Stalman WAB, De Vries ThPGM: Efficacy of temazepam in frequent users: a series of N-of-1 trials. Fam Pract 2005, 22:152-159.
7. Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S: Determing optimal therapy - randomized trials in individual patients. N Engl J Med 1986, 314:889-892.
8. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT: The n-of-1 randomized controlled trial: clinical usefulness, our three-year experience. Ann Intern Med 1990, 112:293-299.
9. Beurskens AJ, De Vet HC, Koke AJ, Lindeman E, Van der Heijden GJ, Regtop W, Knipschild PG: A patient-specific approach for measuring functional status in low back pain. J Manipulative Physiol Ther 1999, 22:144-148.
10. Mahon JL, Laupacis A, Hodder RV, McKim DA, Paterson NA, Wood TE, Donner A: Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest 1999, 115:38-48.
11. Woodfield R, Goodyear-Smith F, Arroll B: N-of-1 trials of quinine efficacy in skeletal muscle cramps of the leg. Br J Gen Pract 2005, 55:181-5.
12. Pope JE, Prashker M, Anderson J: The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. J Rheumatol 2004, 31:140-9.
13. March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P: N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994, 309:1041-1045. discussion 1045-1046
14. Haas DC, Sheehe PR: Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache. Headache 2004, 44:1029-37.
15. Kazdin AE: Statistical analyses for single-case experimental designs. In Single case experimental designs - strategies for studying behavior change 2nd edition. Edited by: Barlow DH, Hersen M. New York: Pergamon Press; 1984:285-324.
16. Onghena P, Edington ES: Randomization tests for restricted alternating treatments designs. Behav Res Ther 1994, 32:783-786.
17. Spiegelhalter DJ: Statistical issues in studies of individual response. Scand J Gastroenterol Suppl 1988, 147:40-45.
18. Jones B, Jarvis P, Lewis JA, Ebbutt AF: Trials to assess equivalence: the importance of rigorous methods. BMJ 1996, 313:36-39.
19. Senn S, Bakshi R, Ezzet N: Caution in interpretation needed. [letter]. BMJ 1995, 310:667.
20. Altman DG: Absence of evidence is not evidence of absence. BMJ 1995, 311:485.
21. Ebutt AF, Frith L: Practical issues in equivalence trials. Stat Med 1998, 17:1691-1701.
22. Hermens ML, Van Hout HP, Terluin B, Ader HJ, De Haan M: The importance of equivalence trials in showing the usefulness oftreatments. [In Dutch: Het belang van equivalentieonderzoek om de waarde van behandelingen aan te tonen]. Ned Tijdschr Geneeskd 2003, 147:2162-2166.
23. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Clavarino A, Yelland MJ: Preliminary experiences with a single-patient trials service in general practice. Med J Aust 2000, 173:100-103.
24. Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM: Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. Rheumatology (Oxford) in press. 2006, Jun 15
25. Kent MA, Camfield CS, Camfield PR: Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med 1999, 153:1292-96.
26. Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N: An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder. Pediatrics 2006, 117:2040-6.
27. Schluter PJ, Ware RS: Single patient (n-of-1) trials with binary treatment preference. Stat Med 2005, 24:2625-36.
28. Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J: Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 1997, 50:401-10.
29. Coxeter PD, Schluter PJ, Eastwood HL, Nikles CJ, Glasziou PP: Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med 2003, 11:215-22.
30. Harker N, Montgomery A, Fahey T: Treating of nausea and vomiting during pregnancy: case presentation. BMJ 2004, 328:276.
31. Harker N, Montgomery A, Fahey T: Treating nausea and vomiting during pregnancy: case progression. BMJ 2004, 328:337.
32. Harker N, Montgomery A, Fahey T: Treating of nausea and vomiting during pregnancy: case outcome. BMJ 2004, 328:503.
33. Campbell MJ: Commentary: statistical aspects. BMJ 2004, 328:506.
34. Johannessen T: Controlled trials in single subjects: Value in clinical medicine. BMJ 1991, 303:173-174.
35. Jull A, Bennett D: Do n-of-1 trials really tailor treatment? Lancet 2005, 365:1992-4.
36. Johnston BC, Mills E: N-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation. J Altern Complement Med 2004, 10:979-84.
37. Guyatt G, Haynes B, Jaeschke R, Cook D, Greenhalgh T, Mead M, Green L, Naylor CD, Wilson M, McAlister F, Richardson WS: Introduction: the philosophy of evidence-based medicine. In Users' guides to the medical literature Edited by: Guyatt G, Rennie D. Chicago: Americal Medical Association Press; 2002:3-11.
38. Nikles CJ, Yelland M, Glasziou PP, Del Mar C: Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain. Am J Ther 2005, 12:92-7.